Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shaoyao Sujing tablet for knee osteoarthritis
ChiCTR-IPR-15006194Phase 2Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- Feb 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Shaoyao Shujing in knee osteoarthritis (OA) (3 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: WOMAC score. Started Feb 2015; status: recruiting.
02
Drugs
Shaoyao Shujing
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-15006194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006194.